The neurobiology of sleep: Genetics, cellular physiology and subcortical networks

Nature Reviews Neuroscience

Volumn 3, Issue 8, 2002, Pages 591-605

  Pace Schott, Edward F ^a   Hobson, J Allan ^a  

^a MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIA;

ANIMAL; AROUSAL; BIOLOGICAL RHYTHM; BRAIN; CIRCADIAN RHYTHM; CYTOLOGY; GENETICS; HUMAN; NERVE CELL NETWORK; NERVE TRACT; PHYSIOLOGY; REM SLEEP; REVIEW; SLEEP;

ANIMALS; AROUSAL; BIOLOGICAL CLOCKS; BRAIN; CIRCADIAN RHYTHM; HUMANS; NERVE NET; NEURAL PATHWAYS; SLEEP; SLEEP, REM;

EID: 0036674614     PISSN: 14710048     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrn895     Document Type: Review

References (154)

1. Allada, R., Emery, P., Takahashi, J. S. & Rosbash, M. Stopping time: the genetics of fly and mouse circadian clocks. Annu. Rev. Neurosci. 24, 1091-1119 (2001).
2. Reppert, S. M. & Weaver, D. R. Molecular analysis of mammalian circadian rhythms. Annu. Rev. Physiol. 63, 647-676 (2001).
3. Rechtschaffen, A. & Bergmann, B. M. Sleep deprivation in the rat: an update of the 1989 paper. Sleep 24, 18-24 (2002).
4. Hobson, J. A. & Pace-Schott, E. F. The cognitive neuroscience of sleep: neuronal systems, consciousness and learning. Nature Rev. Neurosci. (in the press).
5. Kryger, M. H., Roth, T. & Dement, W. C. (eds) Principles and Practice of Sleep Medicine (Saunders, Philadelphia, 2000).
6. Konopka, R. J. & Benzer, S. Clock mutants of Drosophila melanogaster. Proc. Natl Acad. Sci. USA 68, 2112-2116 (1971).
7. Albrecht, U. Regulation of mammalian circadian clock genes. J. Appl. Physiol. 92, 1348-1355 (2002).
8. Czeisler, C. A. et al. Stability, precision, and near 24 hour period of the human circadian pacemaker. Science 284, 2177-2181 (1999).
9. Gillette, M. U. & Tischkau, S. A. Suprachiasmatic nucleus: the brain's clock. Recent Prog. Horm. Res. 54, 33-59 (1999).
10. Welsh, D. K., Logothetis, D. E., Meister, M. & Reppert, S. M. Individual neurons dissociated from rat suprachiasmatic nucleus express independently phased circadian firing rhythms. Neuron 14, 697-706 (1995).
11. Ralph, M. R., Foster, R. G. & Davis, F. C. Transplanted suprachiasmatic nucleus determines circadian period. Science 27, 975-978 (1990).
12. Lowrey, P. L., Shimomura, K., Antoch, M. P., Yamazaki, S. & Zemenides, P. D. Positional cloning and functional characterization of the mammalian circadian mutation tau. Science 288, 483-491 (2000).
13. Vielhaber, E., Eide, E., Rivers, A, Gao, Z. H. & Virshup, D. M. Nuclear entry of the circadian regulator mPER1 is controlled by mammalian casein kinase 1ε. Mol. Cell. Biol. 20, 4888-4899 (2000).
14. Vitanera, M. H., King, D. P., Chang, A. M., Komhauser, J. M. & Lowrey, P. I. Mutagenesis and mapping of a mouse gene Clock, essential for circadian behavior. Science 264, 719-725 (1994).
15. King, D. P., Zhao, Y. Sangoram, A. M., Wilsbacher, L. D. & Tanaka, M. Positional cloning of the mouse circadian Clock gene. Cell 89, 641 -653 (1997).
16. Reid, K. J. et al. Familial advanced sleep phase syndrome. Arch. Neurol. 58, 1089-1094 (2001).
17. Colwell, C. S., Foster, R. G. & Menaker, M. NMDA receptor agonists block the effects of light on circadian behavior in the mouse. Brain Res. 554, 105-110 (1991).
18. Ding, J. M. et al. Resetting the biological clock: mediation of noctumal circadian shifts by glutamate and NO. Science 266, 1713-1717 (1994).
19. Weber, E. T., Gannon, R. L., Michel, A. M., Gillette, M. U. & Rea, M. A. Nitric oxide synthase inhibitor blocks light-induced phase shifts of the circadian activity rhythm, but not c-fos expression in the suprachiasmatic nucleus of the Syrian hamster. Brain Res. 692, 137-142 (1995).
20. Gillette, M. U. et al. Role of the M1 receptor in regulating circadian rhythms. Life Sci. 68, 2467-2472 (2001).
21. MacArthur, A. J., Hunt, A. E. & Gillette, M. U. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: activation of protein kinase at dusk and dawn. Endocrinology 138, 627-634 (1997).
22. Hannibal, J. Pituitary adenylate cyclase activating peptide (PACAP) in the retinohypothalamic tract: a daytime regulator of the biological clock. Ann. NY Acad. Sci. 865, 197-206 (1998).
23. Ding, J. M. et al. A neuronal ryanodine receptor mediates light-induced phase delays of the circadian clock. Nature 394, 381-384 (1998).
24. Tischkau, S. A., Gallman, E. A., Buchanan, G. F. & Gillette, M. U. Differential cAMP gating of glutamatergic signal regulates long-term state changes in the suprachiasmatic circadian clock. J. Neurosci. 20, 7830-7837 (2000).
25. Field, M. D., Maywood, E. S., O'Brien, J. A., Weaver, D. R. & Reppert, S. M. Analysis of clock proteins in mouse SCN demonstrates phylogenetic divergence of the circadian clockwork and resetting mechanisms. Neuron 25, 437-447 (2000).
26. Moore, R. Y. & Speh, J. C. GABA in the mammalian suprachiasmatic nucleus and its role in diurnal rhythmicity. Nature 387, 598-603 (1993).
27. Liu, C. & Reppert, S. M. GABA synchronizes clock cells within the suprachiasmatic circadian clock. Neuron 25, 123-128 (2000).
28. Miche, S. & Colwell, C. S. Cellular communication and coupling within the suprachiasmatic nucleus. Chronobiol. Int. 18, 579-600 (2001).
29. Yagita, K., Tamanini, F., van Der Horst, G. T. & Okamura, H. Molecular mechanisms of the biological clock in cultured fibroblasts. Science 292, 278-281 (2001).
30. Chemelli, R. M. et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98, 437-451 (1999).
31. Lin, L et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98, 365-376 (1999).
32. Kilduff, T. S. & Peyron, C. The hypocretin/orexin ligand-receptor system: implications for sleep and sleep disorders. Trends Neurosci. 23, 359-365 (2000).
33. Sutcliffe, J. G. & De Lecea, L. The hypocretins: setting the arousal threshold. Nature Rev. Neurosci. 3, 339-349 (2002).
34. Cirelli, C. & Tononi, G. On the functional significance of c-fos induction during the sleep/waking cycle. Sleep 23, 453-469 (2000).
35. Tononi, G. & Cirelli, C. Modulation of brain gene expression during sleep and wakefulness: a review of recent findings. Neuropsychopharmacology 25, S28-S35 (2001).
36. Cirelli, C. & Tononi, G. Differences in gene expression between sleep and waking as revealed by mRNA differential display. Brain Res. Mol. Brain Res. 56, 293-305 (1998).
37. Cirelli, C. & Tononi, G. Gene expression in the brain across the sleep-waking cycle. Brain Res. 885, 303-321 (2000).
38. Cirelli, C., Pompeiano, M. & Tononi, G. Neuronal gene expression in the waking state: a role for the locus coeruleus. Science 274, 1211-1215 (1996).
39. Cirelli, C. & Tononi, G. Differential expression of plasticity-related genes in waking and sleep and their regulation by the noradrenergic system. J. Neurosci. 20, 9187-9194 (2000).
40. Peigneux, P., Laureys, S., Delbeuck, X. & Maquet, P. Sleeping brain, learning brain. The role of sleep for memory systems. Neuroreport 12, A111-A124 (2001).
41. Vertes, R. P. & Eastman, K. E. The case against memory consolidation in REM sleep. Behav. Brain Sci. 23, 867-876 (2000).
42. Graves, L., Pack, A. & Abel, T. Sleep and memory: a molecular perspective. Trends Neurosci. 24, 237-243 (2001).
43. Ribeiro, S., Goyal, V., Mello, C. V. & Pavlides, C. Brain gene expression during REM sleep depends on prior waking experience. Learn. Mem. 6, 500-508 (1999).
44. Hobson, J. A., McCarley, R. W. & Wyzinki, P. W. Sleep cycle oscillation: reciprocal discharge by two brainstem neuronal groups. Science 189, 55-58 (1975).
45. McCarley, R. W. & Hobson, J. A. Neuronal excitability modulation over the sleep cycle: a structural and mathematical model. Science 189, 58-60 (1975).
46. Hobson, J. A., Pace-Schott, E. F. & Stickgold, R. Dreaming and the brain: toward a cognitive neuroscience of conscious states. Behav. Brain Sci. 23, 793-842 (2000).
47. Pace-Schott, E. F. & Hobson, J. A. in American College of Neuropsychopharmacology, Fifth Generation of Progress (eds Charney, D., Coyle, J., Davis, K. & Nemeroff, C.) 1859-1877 (Lippincott, Williams and Wilkins, Philadelphia, Pennsylvania, 2002).
48. Leonard, C. S. & Llinas, R. Serotonergic and cholinergic inhibition of mesopontine cholinergic neurons controlling REM sleep: an in vitro electrophysiological study. Neuroscience 59, 309-330 (1994).
49. Sakai, K. & Koyama, Y. Are there cholinergic and non-cholinergic paradoxical sleep-on neurons in the pons? Neuroreport 7, 2449-2453 (1996).
50. Semba, K. in Handbook of Behavioral State Control: Molecular and Cellular Mechanisms (eds Lydic, R. & Baghdoyan, H. A.) 161-180 (CRC Press, Boca Raton, Florida, 1999).
51. Steriade, M., Datta, S., Pare, D., Oakson, G. & Curro-Dossi, R. Neuronal activities in brainstem cholinergic nuclei related to tonic activation processes in thalamocortical systems. J. Neurosci. 10, 2541-2559 (1990).
52. Gervasoni, D. et al. Role and origin of the GABAergic innervation of dorsal raphe serotonergic neurons. J. Neurosci. 20, 4217-4225 (2000).
53. Luppi, P.-H., Peyron, C. & Rampon, C. in Handbook of Behavioral State Control: Molecular and Cellular Mechanisms (eds Lydic, R. & Baghdoyan, H.) 195-211 (CRC Press, Boca Raton, Florida, 1999).
54. Maloney, K. J., Mainville, L. & Jones, B. E. Differential c-fos expression in cholinergic, aminergic and GABAergic cell groups of the pontomesencephalic tegmentum after paradoxical sleep deprivation and recovery. J. Neurosci. 19, 3057-3072 (1999).
55. Nitz, D. & Siegel, J. M. GABA release in the locus coeruleus as a function of sleep/wake state. Neuroscience 78, 795-801 (1997).
56. Nitz, D. & Siegel, J. M. GABA release in the dorsal raphe nucleus: role in the control of REM sleep. Am. J. Physiol. 273, R451-R455 (1997).
57. 2A receptor-like protein is present in small neurons located in rat mesopontine cholinergic nuclei, but absent from cholinergic neurons. Neurosci. Lett. 314, 77-81 (2001).
58. Blanco-Centurion, C. A. & Salin-Pascual, R. J. Extracellular serotonin levels in the medullary reticular formation during normal sleep and after REM sleep deprivation. Brain Res. 923, 128-136 (2001).
59. Vazquez, J. & Baghdoyan, H. A. Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280, R598-P601 (2001).
60. Jones, B. E. in Principles and Practice of Sleep Medicine (eds Kryger, M. H., Roth, T. & Dement, W. C.) 134-154 (Saunders, Philadelphia, 2000).
61. Kubin, L. Carbachol models of REM sleep: recent developments and new directions. Arch. Ital. Biol. 139, 37-51 (2001).
62. Sakai, K., Crochet, S. & Onoe, H. Pontine structures and mechanisms involved in the generation of paradoxical (REM) sleep. Arch. Ital. Biol. 139, 93-107 (2001).
63. Capece, M. C., Baghdoyan, H. A. & Lydic, R. in Rapid Eye Movement Sleep (eds Mallick, B. N. & Inoue, S.) 123-141 (Marcel Dekker, New York, 1999).
64. Luppi, P.-H. et al. in Rapid Eye Movement Sleep (eds Mallick, B. N. & Inoue, S.) 107-122 (Marcel Dekker, New York, 1999).
65. Jacobs, B. L. & Fornal, C. A. in Handbook of Behavioral State Control: Molecular and Cellular Mechanisms (eds Lydic, R. & Baghdoyan, H. A.) (CRC Press, Boca Raton, Florida, 1999).
66. Hobson, J. A. & Steriade, M. in Handbook of Physiology -The Nervous System Vol. IV (ed. Bloom, F. E.) 701-823 (American Physiological Society, Bethesda, Maryland, 1986).
67. Steriade, M. & McCarley, R. W. Brainstem Control of Wakefulness and Sleep (Plenum, New York, 1990).
68. Datta, S. in Rapid Eye Movement Sleep (eds Mallick, B. N. & Inoue, S.) 91-106 (Marcel Dekker, New York, 1999).
69. B receptors in the median raphe nucleus: distribution and role in the serotonergic control of hippocampal activity. Neuroscience 109, 119-132 (2002).
70. Vertes, R. & Kocsis, B. Brainstem-diencephaloseptohippocampal systems controlling the theta rhythm of the hippocampus. Neuroscience 81, 893-926 (1997).
71. Lai, Y. Y. & Siegel, J. M. in Rapid Eye Movement Sleep (eds Mallick, B. N. & Inoue, S.) 69-70 (Marcel Dekker, New York, 1999).
72. Lydic, R. & Baghdoyan, H. A. (eds) Handbook of Behavioral State Control: Molecular and Cellular Mechanisms (CRC Press, Boca Raton, Florida, 1999).
73. Mallick, B. N. & Inoue, S. (eds) Rapid Eye Movement Sleep (Marcel Dekker, New York, 1999).
74. Saper, C. B., Chou, T. C. & Scammell, T. E. The sleep switch: hypothalamic control of sleep and wakefulness. Trends Neurosci. 24, 726-731 (2001).
75. Steininger, T. L., Alam, M. N., Gong, H., Szmusiak, R. & McGinty, D. Sleep-waking discharge of neurons in the posterior lateral hypothalamus of the albino rat. Brain Res. 840, 138-147 (1999).
76. Miller, J. D., Farber, J., Gatz, P., Roffwarg, H. & German, D. C. Activity of mesencephalic dopamine and non-dopamine neurons across stages of sleep and waking in the rat. Brain Res. 273, 133-141 (1983).
77. Trulson, M. E., Preussler, D. W. & Howell, A. G. Activity of the substantia nigra across the sleep-wake cycle in freely moving cats. Neurosci. Lett. 26, 183-188 (1981).
78. Rye, D. B. & Jankovic, J. Emerging views of dopamine in modulating sleep/wake state from an unlikely source: PD. Neurology 58, 341-346 (2002).
79. Lu, J., Xu, M. & Saper, C. B. Identification of wake-active dopaminergic neurons in the ventral periaqueductal gray (PAG). Sleep 25, A290 (2002).
80. Gillin, J. C. et al. REM inhibitory effect of L-DOPA infusion during human sleep. Electroencephalogr. Clin. Neurophysiol. 35, 181-186 (1973).
81. Nofzinger, E. A. et al. REM sleep enhancement by bupropion in depressed men. Am. J. Psychiatry 152, 274-276 (1995).
82. Nunes, G. P. Jr, Tufik, S. & Nobrega, J. N. Autoradiographic analysis of D1 and D2 dopaminergic receptors in rat brain after paradoxical sleep deprivation. Brain Res. Bull. 34, 453-456 (1994).
83. Freeman, A. et al. Nigrostriatal collaterals to thalamus degenerate in parkinsonian animal models. Ann. Neurol. 50, 321-329 (2001).
84. Xi, M. C., Morales, F. R. & Chase, M. H. Induction of wakefulness and inhibition of active sleep by GABAergic processes in the nucleus pontis oralis. Arch. Ital. Biol. 139, 125-145 (2001).
85. Boissard, R. et al. Neuronal networks responsible for paradoxical sleep onset and maintenance in rats: a new hypothesis. Sleep 23, A107 (2000).
86. Chase, M. H., Soja, P. J. & Morales, F. R. Evidence that glycine mediates the post synaptic potentials that inhibit lumbar motorneurons during the atonia of active sleep. J. Neurosci. 9, 743-751 (1989).
87. Steriade, M. Active neocortical processes during quiescent sleep. Arch. Ital. Biol. 139, 37-51 (2001).
88. Leonard, T. O. & Lydic, R. in Rapid Eye Movement Sleep (eds Mallick, B. N. & Inoue, S.) 167-193 (Marcel Dekker, New York, 1999).
89. Williams, J. A., Vincent, S. R. & Reiner, P. B. Nitric oxide production in rat thalamus changes with behavioral state, local depolarization and brainstem stimulation. J. Neurosci. 17, 420-427 (1997).
90. Leonard, T. O., Michaelis, E. K. & Mitchell, K. M. Activity-dependent nitric oxide concentration dynamics in the laterodorsal tegmental nucleus in vivo. J. Neurophysiol. 86, 2159-2172 (2001).
91. G-nitro-L-arginine increases basal forebrain acetylcholine release during sleep and wakefulness. J. Neurosci. (in the press).
92. Braun, A. R. et al. Regional cerebral blood flow throughout the sleep-wake cycle. Brain 120, 1173-1197 (1997).
93. Steiger, A. & Holsboer, F. Neuropeptides and human sleep. Sleep 20, 1038-1052 (1997).
94. Obal, F. & Krueger, J. M. in Rapid Eye Movement Sleep (eds Mallick, B. N. & Inoue, S.) 233-247 (Marcel Dekker, New York, 1999).
95. Sherin, J. E., Shiromani, P. J., McCarley, R. W. & Saper, C. B. Activation of ventrolateral preoptic neurons during sleep. Science 271, 216-219 (1996).
96. Shiromani, P. J., Scammell, T., Sherin, J. E. & Saper, C. B. in Handbook of Behavioral State Control: Molecular and Cellular Mechanisms (eds Lydic, R. & Baghdoyan, H. A.) 311-325 (CRC Press, Boca Raton, Florida, 1999).
97. Gallopin, T. et al. Identification of sleep-promoting neurons in vitro. Nature 404, 992-995 (2000).
98. Sherin, J. E., Elmquist, J. K., Torrealba, F. & Saper, C. B. Innervation of histaminergic tuberomammilary neurons by GABAergic and galininergic neurons in the ventrolateral preoptic nucleus of the rat. J. Neurosci. 18, 4705-4721 (1998).
99. Steininger, T. L., Gong, H., McGinty, D. & Szmusiak, R. Subregional organization of preoptic area/anterior hypothalamic projections to arousal-related monoaminergic cell groups. J. Comp. Neurol. 429, 638-653 (2001).
100. Yang, Q. Z. & Hatton, G. I. Excitatory and inhibitory inputs to histaminergic tuberomammilary nucleus. Brain Res. 773, 162-172 (1997).
101. Lu, J., Greco, M. A., Shiromani, P. & Saper, C. Effect of lesions of the ventrolateral preoptic nucleus on NREM and REM sleep. J. Neurosci. 20, 3830-3842 (2000).
102. Panula, P., Pirvola, U., Auvinen, S. & Airaksinen, M. S. Histamine-immunoreactive fibers in the rat brain. Neuroscience 28, 585-610 (1989).
103. Lin, J. S., Hou, Y., Sakai, K. & Jouvet, M. Histaminergic descending inputs to the mesopontine tegmentum and their role in the control of cortical activation and wakefulness in the cat. J. Neurosci. 16, 1523-1537 (1996).
104. Chou, T. C. et al. Afferents to the ventrolateral preoptic nucleus. J. Neurosci. 22, 977-990 (2002).
105. Piper, D. C., Upton, N., Smith, M. J. & Hunter, A. J. The novel brain neuropeptide, orexin-A, modulates the sleep-wake cycle of rats. Eur. J. Neurosci. 12, 726-730 (2000).
106. Thakkar, M. M., Ramesh, V., Strecker, R. E. & McCarley, R. W. Microdialysis perfusion of orexin-A in the basal forebrain increases wakefulness in freely behaving rats. Arch. Ital. Biol. 139, 313-328 (2001).
107. Horvath, T. L. et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J. Comp. Neurol. 415, 145-159 (1999).
108. Aston-Jones, G., Chen, S., Zhu, Y. & Oshinsky, M. L. A neural circuit for circadian regulation of arousal. Nature Neurosci. 4, 732-738 (2001).
109. Moore, R. Y., Abrahamson, E. A. & Van Den Pol, A. The hypocretin neuron system: an arousal system in the human brain. Arch. Ital. Biol. 139, 2195-2205 (2001).
110. Peyron, C. et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nature Med. 6, 991-997 (2000).
111. Thannickal, T. C. et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27, 469-474 (2000).
112. Nishino, S., Ripley, B., Overeem, S., Lammers, G. J. & Mignot, E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355, 39-40 (2000).
113. Methippara, M. M., Alam, M. N., Szymusiak, R. & McGinty, D. Effects of lateral preoptic area application of orexin-A on sleep-wakefulness. Neuroreport 11, 3423-3426 (2000).
114. Eggermann, E. et al. Orexins/hypocretins excite basal forebrain cholinergic neurones. Neuroscience 108, 177-181 (2001).
115. Bernard, R., Lydic, R. & Baghdoyan, H. A. Hypocretin-1 activates G proteins in arousal-related brainstem nuclei of rat. Neuroreport 13, 447-450 (2002).
116. Porkka-Heiskanen, T., Strecker, R. E. & Thakkar, M. Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science 276, 1265-1268 (1997).
117. Strecker, R. E. et al. Adenosinergic modulation of basal forebrain and preoptic/anterior hypothalamic neuronal activity in the control of behavioral state. Behav. Brain Res. 115, 183-204 (2000).
118. Borbely, A. A. From slow waves to sleep homeostasis: new perspectives. Arch. Ital. Biol. 139, 53-61 (2001).
119. Porkka-Heiskanen, T., Strecker, R. E. & McCarley, R. W. Brain site specificity of extracellular adenosine concentration changes during sleep deprivation and spontaneous sleep: an in vivo microdialysis study. Neuroscience 99, 507-517 (2000).
120. Basheer, R., Rannie, D. G., Porkka-Heiskanen, T., Ramesh, V. & McCarley, R. W. Adenosine, prolonged wakefulness, and A1-activated NF-κB DNA binding in the basal forebrain of the rat. Neuroscience 104, 731-739 (2001).
121. Krueger, J. M., Obal, F. & Fang, J. Humoral regulation of physiological sleep: cytokines and GHRH. J. Sleep Res. 8 (Suppl. 1), 53-59 (1999).
122. Mendelson, W. B. & Basile, A. S. The hypnotic actions of the fatty acid oleamide. Neuropsychopharmacology 25, S36-S39 (2001).
123. Semba, K., Pastorius, J., Wilkinson, M. & Rusak, B. Sleep deprivation-induced c-fos and junB expression in the rat brain: effects of duration and timing. Behav. Brain Res. 120, 75-86 (2001).
124. Sun, X., Rusak, B. & Semba, K. Bectrophysiology and pharmacology of projections from the suprachiasmatic nucleus to the ventrolateral preoptic area in rat. Neuroscience 98, 715-728 (2000).
125. Berson, D. M., Dunn, F. A. & Takao, M. Phototransduction by retinal ganglion cells that set the circadian clock. Science 295, 1070-1073 (2002).
126. Hannibal, J., Hindersson, P., Knudsen, S. M., Georg, B. & Fahrenkrug, J. The photopigment melanopsin is exclusively present in pituitary adenylate cyclase-activating polypeptide-containing retinal ganglion cells of the retinohypothalamic tract. J. Neurosci. 22, RC191 (2002).
127. Hattar, S. et al. Melanopsin-containing retinal ganglion cells: architecture, projections, and intrinsic photosensitivity. Science 295, 1065-1069 (2002).
128. Gooley, J. J., Lu, J., Chou, T. C., Scamell, T. E. & Saper, C. B. Melanopsin in cells of origin of the retinohypothalamic tract. Nature Neurosci. 4, 1165 (2001).
129. Provencio, I. et al. A novel human opsin in the inner retina. J. Neurosci. 20, 600-605 (2000).
130. Chou, T. C., Scammell, T., Lu, J., Shiromani, P. & Saper, C. Excitotoxic lesions of the dorsomedial hypothalamic nucleus markedly attenuate circadian rhythms of sleep and body temperature. Soc. Neurosci. Abstr. 26, 1264 (2000).
131. Lu, J. et al. Contrasting effects of ibotenate lesions of the paraventricular nucleus and subparaventricular zone on sleep-wake cycle and temperature regulation. J. Neurosci. 21, 4864-4874 (2001).
132. Abrahamson, E. E., Leak, R. K. & Moore, R. Y. The suprachiasmatic nucleus projects to posterior hypothalamic arousal systems. Neuroreport 12, 435-440 (2001).
133. Hagan, J. J. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc. Natl Acad. Sci. USA 96, 10911-10916 (1999).
134. Wurts, S. & Edgar, D. Circadian and homeostatic control of rapid eye movement (REM) sleep: promotion of REM tendency by the suprachiasmatic nucleus. J. Neurosci. 20, 4300-4310 (2000).
135. Van Cauter, E. & Turek, F. W. in Endocrinology (ed. DeGroot, L. J.) 2487-2548 (Saunders, Philadelphia, 1995).
136. Czeisler, C. A. & Khalsa, S. S. in Principles and Practice of Sleep Medicine (eds Kryger, M. H., Roth, T. & Dement, W. C.) 353-375 (Saunders, Philadelphia, 2000).
137. McGinty, D. & Szymusiak, R. Keeping cool: a hypothesis about the mechanisms and functions of slow-wave sleep. Trends Neurosci. 13, 480-487 (1990).
138. Teclemariam-Mesbah, R., Ter Horst, G. J., Fostema, F., Wotet, J. & Buijs, R. M. Anatomical demonstration of the suprachiasmatic nucleus-pineal gland. J. Comp. Neurol. 406, 171-182 (1999).
139. Wehr, T. A. Melatonin and seasonal rhythms. J. Biol. Rhythms 12, 518-527 (1997).
140. Liu, C., Weaver, D. R., Jin, X., Shearman, L. P. & Pieschl, R. L. Molecular dissection of two distinct actions of melatonin on the suprachiasmatic circadian clock. Neuron 19, 91-102 (1997).
141. von Gall, C. et al. CREB in the mouse SCN: a molecular interface coding the phase-adjusting stimuli light, glutamate, PACAP, and melatonin for clockwork access. J. Neurosci. 18, 10389-10397 (1998).
142. Leak, R. K. & Moore, R. Y. Topographic organization of suprachiasmatic nucleus projection neurons. J. Comp. Neurol. 433, 312-334 (2001).
143. Krout, K. E., Kawano, J., Mettenleiter, T. C. & Loewy, A. D. CNS inputs to the suprachiasmatic nucleus of the rat. Neuroscience 110, 73-92 (2002).
144. Gaspar, P., Berger, B., Febvret, A., Vigny, A. & Henry, J. P. Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine-β-hydroxylase. J. Comp. Neurol. 279, 249-271 (1989).
145. Mesulam, M.-M., Hersh, L. B., Mash, D. C. & Geula, C. Differential cholinergic innervation within functional subdivisions of the human cerebral cortex: a choline acetyltransferase study. J. Comp. Neurol. 318, 316-328 (1992).
146. Panula, P., Airaksinen, M. S., Pirvola, U. & Kotilainen, E. A histamine containing neuronal system in the human brain. Neuroscience 34, 127-132 (1990).
147. Wilson, M. A. & Molliver, M. E. The organization of serotonergic projections to cerebral cortex in primates: regional distribution of axon terminals. Neuroscience 44, 537-553 (1991).
148. Hasselmo, M. Neuromodulation: acetylcholine and memory consolidation. Trends Cogn. Sci. 3, 351-359 (1999).
149. Morrison, A. R., Sanford, L. D. & Ross, R. J. in Rapid Eye Movement Sleep (eds Mallick, B. N. & Inoue, S.) 51-68 (Marcel Dekker, New York, 1999).
150. Rechtschaffen, A. & Kales, A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects (Brain Information Service/Brain Research Institute, University of California at Los Angeles, 1968).
151. Aserinsky, E. & Kleitman, N. Regularly occurring periods of ocular motility and concomitant phenomena during sleep. Science 118, 361-375 (1953).
152. Hobson, J. A. Sleep (Scientific American Library, New York, 1989).
153. Williams, J. A., Comisarow, J., Day, J., Fibiger, H. C. & Reiner, P. B. State-dependent release of acetylcholine in rat thalamus measured by in vivo microdialysis. J. Neurosci. 14, 5236-5242 (1994).
154. Jones, B. E. & Muhlethaler, M. in Handbook of Behavioral State Control: Molecular and Cellular Mechanisms (eds Lydic, R. & Baghdoyan, H. A.) 213-233 (CRC Press, Boca Raton, Florida, 1999).